Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

2.

Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY.

World J Gastroenterol. 2007 Feb 21;13(7):1018-26.

3.
4.

Loss of fragile histidine triad expression in colorectal carcinoma.

Zhao P, Lu Y, Hu Y, Zhong M, Li Z, Li X.

Zhonghua Bing Li Xue Za Zhi. 2002 Apr;31(2):124-7.

PMID:
12419158
5.

Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.

Li H, Zhao P, Lu Y, Lu Y.

Int J Colorectal Dis. 2012 Aug;27(8):1015-20. Epub 2012 Feb 9.

PMID:
22315171
6.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

7.
8.

Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.

Cao J, Li W, Xie J, Du H, Tang W, Wang H, Chen X, Xiao W, Li Y.

Surg Oncol. 2006 Dec;15(4):223-33. Epub 2007 Mar 26.

PMID:
17382535
9.

Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.

Wierzbicki PM, Adrych K, Kartanowicz D, Dobrowolski S, Stanislawowski M, Chybicki J, Godlewski J, Korybalski B, Smoczynski M, Kmiec Z.

J Physiol Pharmacol. 2009 Oct;60 Suppl 4:63-70.

10.

Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.

Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA.

Cancer. 2000 Jan 1;88(1):24-34.

PMID:
10618602
11.
12.

Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.

Zhao P, Liu W, Lu YL.

World J Gastroenterol. 2005 Sep 28;11(36):5735-8.

13.

Involvement of galectin-3 expression in colorectal cancer progression and metastasis.

Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M.

Int J Oncol. 1999 Jul;15(1):143-8.

PMID:
10375607
15.

Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.

Luceri C, Guglielmi F, De Filippo C, Caderni G, Mini E, Biggeri A, Napoli C, Tonelli F, Cianchi F, Dolara P.

Scand J Gastroenterol. 2000 Jun;35(6):637-41.

PMID:
10912665
16.
17.

Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.

Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE.

Int J Colorectal Dis. 2002 Nov;17(6):396-401. Epub 2002 May 29.

PMID:
12355215
18.

Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.

Nan KJ, Ruan ZP, Jing Z, Qin HX, Wang HY, Guo H, Xu R.

World J Gastroenterol. 2005 Jan 14;11(2):228-31.

19.

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M.

Cancer Res. 2006 Mar 1;66(5):2683-90.

20.

Supplemental Content

Support Center